Link between trauma & eating | ChicagoNOW

Weight-loss trends have been around for years, with the latest being GLP1 drugs like Ozempic or Wegovy. Meg Bowman, licensed nutritionist and trauma expert weighs in on what's causing these weight loss crazes.

Trump announces price cuts on Wegovy, Zepbound

President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity treatments Zepbound and Wegovy. Here’s what we know.

New melatonin study raises heart health concerns — what doctors say you should know | ChicagoLIVE

A new American Heart Association report has people asking whether melatonin—the popular sleep aid—could pose heart health risks with long-term use. "ChicagoLIVE" speaks with Dr. Tochukwu M. Okwuosa of Rush University Medical Center, who explains what the study actually shows, why it’s too early to link melatonin directly to heart disease, and what patients should know before using sleep supplements.